New test could help physicians predict people who are at early stages of sepsis

NewsGuard 100/100 Score

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

Sepsis, a syndrome caused by infection, leads to organ failure and is responsible for up to five million deaths annually. There are 18 million cases of sepsis worldwide every year. 

The discovery could cut back on the lengthy diagnostic time usually required to confirm if a patient is suffering from sepsis and increase the odds that they will respond to treatment. 

"We identified a gene signature that is associated with the eventual diagnosis of sepsis and subsequent organ failure," says Bob Hancock, a professor in UBC's Dept. of Microbiology and Immunology who co-authored this study with John Boyd, a physician at St Paul's Hospital and an assistant professor at UBC. "We can test for this genetic signature as soon as the patient arrives in the emergency ward."

A typical diagnosis can take 24 to 48 hours but with this new test, physicians could start treating patients almost immediately.

The new test for the genetic signature, published recently in the journal EBioMedicine, would take as little as one hour and identified 96 per cent of patients who were at the very early stages of sepsis.

"With sepsis, every hour counts," says Hancock. "The treatment involves aggressive antibiotics but the most potent drugs can't be administered until a diagnosis is confirmed because of the risk of antibiotic resistant bacteria."

The findings also reveal a potential misunderstanding about the disease. Until now sepsis has been treated as an inflammatory disease but more than 30 clinical trials of anti-inflammatory drugs for sepsis have failed. The gene signature identified by Hancock and his colleagues relates to a special type of immune suppression called cellular reprogramming and suggests that treating inflammation in sepsis is a bad idea.

SOURCE University of British Columbia

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals limitations of AI in early sepsis detection